Sean Laaman

Stock Analyst at Morgan Stanley

(2.92)

# 1,475

Out of 4,760 analysts

2

Total ratings

100%

Success rate

43.84%

Average return

Main Sectors:

Top Industries:

Biotechnology Medical Instruments & Supplies

Stocks Rated by Sean Laaman

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	ALEC Alector	Assumes: Underweight	$3 → $1.5	$1.39	+7.91%	1	Mar 7, 2025
	RMD ResMed	Upgrades: Overweight	$169	$236.63	-28.58%	1	Oct 27, 2023

Alector

Mar 7, 2025

Assumes: Underweight

Price Target: $3 → $1.5

Current: $1.39

Upside: +7.91%

ResMed

Oct 27, 2023

Upgrades: Overweight

Price Target: $169

Current: $236.63

Upside: -28.58%